Structural elucidation of the neuraminidase inhibitor zanamivir (relenza): Creeping and diffusion for polymorph separation

Naba K. Nath, Nobuhiro Yasuda, Wael M. Rabeh, Subash Chandra Sahoo, Panče Naumov

Research output: Contribution to journalArticle

Abstract

Zanamivir, the active ingredient of the antiviral drug Relenza, is the most potent of the four currently approved neuraminidase inhibitors for treatment of pandemic strains of influenza. A combination of solution creeping and vapor diffusion of antisolvent was successfully applied to obtain two crystalline polymorphic dihydrates and to accomplish the first structure determination of zanamivir with X-ray diffraction.

Original languageEnglish (US)
Pages (from-to)770-774
Number of pages5
JournalCrystal Growth and Design
Volume14
Issue number2
DOIs
StatePublished - Feb 5 2014

    Fingerprint

ASJC Scopus subject areas

  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics

Cite this